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Anaerobiosis influences virulence 
properties of Pseudomonas 
aeruginosa cystic fibrosis 
isolates and the interaction with 
Staphylococcus aureus
Ross Pallett1, Laura J. Leslie2, Peter. A. Lambert1, Ivana Milic  1, Andrew Devitt  1 & 
Lindsay J. Marshall1,3
The airways of individuals with cystic fibrosis (CF) are abundantly colonised by Staphylococcus 
aureus and Pseudomonas aeruginosa. Co-infecting hypoxic regions of static mucus within CF airways, 
together with decreases in pulmonary function, mucus plugging and oxygen consumption by host 
neutrophils gives rise to regions of anoxia. This study determined the impact of anaerobiosis upon S. 
aureus-P. aeruginosa interactions in planktonic co-culture and mixed species biofilms in vitro. Whilst 
anoxia reduced the ability for P. aeruginosa CF isolates to dominate over S. aureus, this occurred in 
an isolate dependent manner. Investigations into the underlying mechanisms suggest that the anti-
staphylococcal compound facilitating P. aeruginosa dominance under normoxia and anoxia is greater 
than 3 kDa in size and is heat-stable. Not all interspecies interactions studied were antagonistic, as S. 
aureus exoproducts were shown to restore and enhance P. aeruginosa motility under normoxia and 
anoxia in an isolate dependent manner. Collectively, this study suggests changes in oxygen availability 
within regions of the CF lung is likely to influence interspecies interactions and in turn, potentially 
influence disease progression.
Cystic fibrosis (CF) is the most common inherited genetic condition in the Caucasian population. An autoso-
mal recessive disorder, CF arises due to mutations in the cystic fibrosis transmembrane conductance regula-
tor (CFTR)1, an ion channel belonging to the ATP-Binding Cassette Transporter family of membrane proteins. 
Mutations within the CFTR lead to defective apical chloride ion transport, sodium hyperabsorption and a 
decrease in cell surface liquid2,3. This ultimately results in the production of highly viscous dehydrated mucus, 
affecting the normal physiology of numerous organs3. Impairment in mucociliary clearance within CF airways 
predisposes individuals to the development of several opportunistic respiratory infections, typically occurring in 
a highly-sequential, age-dependent manner4.
A commensal of the anterior nares5, the Gram-positive coccus Staphylococcus aureus (S. aureus) is often the 
first bacterium to be isolated from the sputum of children with CF and remains one of the most prevalent patho-
gens throughout the first decade of life6,7. CF airways are colonised by a complex polymicrobial community, with 
acquisition of the Gram-negative organism Pseudomonas aeruginosa (P. aeruginosa) typically occurring through 
environmental colonisation8, although patient-patient transmission has been shown to facilitate the spread of 
drug resistant epidemic strains9,10. As an individual progresses through adolescence and into early adulthood, P. 
aeruginosa replaces S. aureus as the dominant pathogen in CF airways7,11. There is temporal phenotypic diversity 
of P. aeruginosa during the course of CF airway infection12,13. Compared to the early infecting environmental 
strain, chronic infection with P. aeruginosa is associated with a loss of motility, loss of quorum sensing, the acqui-
sition of the mucoid phenotype and increased resistance to antibiotics14,15.
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The ability of P. aeruginosa to dominate has been attributed to an arsenal of extracellular virulence prop-
erties, several of which target S. aureus. The staphylolytic protease elastase A (LasA) degrades the peptidogly-
can cell wall of S. aureus16, whilst the phenazine pyocyanin and secondary metabolites hydrogen cyanide and 
2-heptyl-4-hydroxyquinoline N-oxide (HQNO) inhibit S. aureus oxidative respiration, consequently slowing its 
growth17–19. Despite this antagonism, S. aureus is detected in a third of CF adults who are culture positive for P. 
aeruginosa7,20, with two recent studies suggesting S. aureus and P. aeruginosa occupy identical regional niches of 
the CF lung21,22. Co-infection of CF airways with S. aureus and P. aeruginosa has been associated with decreased 
pulmonary function and an increased frequency of pulmonary exacerbations compared to mono-infection20,23.
Studies assessing polymicrobial CF airway infection to date, including S. aureus-P. aeruginosa interactions, 
have been conducted under normoxia (21% environmental oxygen), with vigorous culture aeration (200–
250 rpm)18,24–29. However, increases in CF epithelia respiration, thick mucus plugging, decreased pulmonary 
function and oxygen consumption by polymicrobial communities and host neutrophils encourage the devel-
opment of a static growth environment, with very low to absent levels of oxygen30–34. The presence of obligate 
anaerobes has also been shown to contribute to disease severity and inflammation in CF airways35–37.
Though P. aeruginosa is a facultative anaerobe that preferably uses aerobic respiration, its ability to undergo 
anaerobiosis is due to the presence of nitrate (NO3−), which acts as an end terminal electron acceptor38,39. Nitrate 
has been detected in both airway surface liquid (ASL) and in CF airway sputum31,32,40. A microarray study of 
P. aeruginosa obtained from CF sputum detected genes essential for P. aeruginosa denitrification41, whilst sera 
from individuals with CF have also been shown to contain antibodies to P. aeruginosa proteins involved in 
denitrification42.
Whilst anaerobiosis has previously been shown to influence the P. aeruginosa phenotype including growth, 
virulence and sensitivity to antibiotics31,43–48, its impact upon the interactions of P. aeruginosa with other CF 
pathogens has yet to be investigated. Initial experiments in this study sought to determine the impact of normoxia 
and anoxia upon the in vitro interactions between S. aureus and CF clinical isolates of P. aeruginosa in planktonic 
co-culture and mixed species biofilms, the two modes of P. aeruginosa growth known to occur in the CF lung. 
To provide insight into the mechanisms driving interspecies interactions under different oxygen conditions, the 
impact of anaerobiosis upon the production of several anti-staphylococcal exoproducts produced by P. aeruginosa 
were studied, which was further assessed using size fractionation and heat-treatment. Lastly, the impact of anaer-
obiosis and S. aureus exoproducts upon P. aeruginosa motility was determined. Data from this study suggest that 
oxygen availability exerts an isolate dependent effect upon S. aureus-P. aeruginosa interactions that influences the 
predominance of each organism within different regions of the CF lung.
Results
Effect of oxygen availability upon S. aureus-P. aeruginosa competition in planktonic co-culture. 
We sought to identify whether changes in oxygen availability influenced S. aureus-P. aeruginosa interactions in 
planktonic (free-swimming) culture. Reference strain P. aeruginosa PAO1 and P. aeruginosa CF isolates 5, 6 and 
7 were selected for analysis following the growth inhibition results of the agar plate cross-streak assay (shown in 
Supplementary Fig. S1). PAO1 and P. aeruginosa CF clinical isolates 5 and 7 were able to inhibit S. aureus under 
normoxia, whilst CF isolate 6 had no effect upon the growth of S. aureus. Additionally, preliminary experiments 
demonstrated that these CF isolates differed with regards to protease production (assessed on skimmed milk 
agar) and pyocyanin (following bacterial culture upon Pseudomonas isolation agar). S. aureus ATCC 6538 was 
chosen due to it being an accessible and widely used laboratory reference strain. In addition to being known to 
produce biofilm, (important for the co-species biofilm studies)49, it has also been previously used to study S. 
aureus-P. aeruginosa interactions50. Furthermore, it has had its complete genome sequenced51, which may aid in 
determining the virulence properties it is likely to exhibit.
Density matched S. aureus and P. aeruginosa cultures were inoculated at an equal ratio, with planktonic 
growth competition being assessed over 24 h, comparing the colony counts of the bacteria grown in pure culture, 
to those grown in co-culture. To clearly compare the differences of growth in monoculture with co-culture, the 
competitive index (CI) and relative increase ratio (RIR) were calculated.
As shown in Fig. 1 (left panel), all P. aeruginosa isolates tested were able to outcompete S. aureus under 
normoxia. PAO1 and CF isolates 5 and 7 caused an approximate 2.5 log reduction in viable S. aureus at 24 h 
(P < 0.001), whilst CF isolate 6 caused an approximate 1.5 log reduction in S. aureus at 24 h (P < 0.001). The CI 
of PAO1 versus S. aureus was significantly different from the RIR at 2, 3, 5, 6 and 24 h, whilst the CI for all CF 
isolates was significantly higher than the RIR at 6 and 24 h time points only (Supplementary Fig. S2). S. aureus 
killing was incomplete under normoxia for PAO1 and the CF isolates tested, with S. aureus still being detected at 
high bacterial counts at 24 h.
Similar experiments were conducted to determine the effects of anoxia upon co-culture competition (Fig. 1, 
right panel). S. aureus growth was unaffected by the presence of P. aeruginosa PAO1 and CF isolates 5 and 6 at 
all time points tested (see Supplementary Fig. S2), whilst CF isolate 7 retained its ability to dominate, causing an 
approximate 1 log reduction in the growth of S. aureus at 24 h compared to monoculture (P < 0.001).
Oxygen availability and community composition in mixed species biofilms. As S. aureus and P. 
aeruginosa often co-exist within a polymicrobial biofilm within the CF lung, we determined the impact of oxygen 
availability upon the number of viable bacteria within single and mixed biofilms.
Under normoxia (Fig. 2a), S. aureus numbers were reduced in the presence of PAO1 (P < 0.01) and CF isolates 
5 and 7 (P < 0.001), compared to S. aureus alone. Unlike in planktonic culture (Fig. 1), CF isolate 6 was unable to 
outcompete S. aureus in mixed species biofilm. Furthermore, S. aureus was unable to exert an antagonistic affect 
upon any of the P. aeruginosa isolates tested (Fig. 2b), with isolates of P. aeruginosa being recovered in numbers 
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comparable to those isolated in single species biofilm. CF isolate 7 however, demonstrated a significant increase 
in CFU/mL in mixed species biofilm compared to single culture (P < 0.05).
Following growth under anoxia, PAO1 and CF isolates 5 and 6 were no longer able to outcompete S. aureus in 
mixed species biofilm (Fig. 2c) whilst CF isolate 7 retained its ability to reduce S. aureus viability (P < 0.001). All 
CF isolates tested were unaffected by the presence of S. aureus under anoxia with P. aeruginosa being enumerated 
at numbers similar to those in P. aeruginosa monoculture biofilms (Fig. 2d). The data for S. aureus-P. aeruginosa 
competition in planktonic co-culture and mixed species biofilms is summarised in a table in Supplementary 
Table S1.
Figure 1. S. aureus-P. aeruginosa competition in planktonic co-culture under normoxia and anoxia. S. aureus and 
P. aeruginosa were grown statically at 37 °C for 24 h in either single or dual culture, under normoxia or anoxia. At 
regular intervals, aliquots were taken and plated onto selective agar. Each data point represents the mean ± S.E.M 
of three independent experiments (N = 3), each performed in triplicate. Statistical differences were determined 
using a two-way ANOVA with Bonferroni post-hoc, comparing the CI to the RIR at each time point ***P < 0.001.
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Impact of oxygen upon anti-staphylococcal exoproducts. It is evident that anoxia facilitates S. 
aureus-P. aeruginosa co-existence in an isolate dependent manner, in both planktonic co-culture and mixed spe-
cies biofilms. To determine how oxygen availability permits bacterial co-existence and why P. aeruginosa CF iso-
late 7 was still able to reduce S. aureus viability, the production of several known anti-staphylococcal exoproducts 
in cell-free supernatants of P. aeruginosa were assessed following growth under normoxia and anoxia. This study 
focused upon the production of proteases, the lysis of S. aureus, the production of the respiratory inhibitor pyo-
cyanin, the siderophore pyoverdine and biosurfactants.
As P. aeruginosa is known to secrete a number of proteases, skimmed milk agar has previously been used 
to study the total protease activity of P. aeruginosa50,52. The diameter of the zones of clearance were measured 
in millimetres (mm). As shown in Fig. 3a, PAO1 and CF isolates 5 and 7 produced detectable levels of protease 
under normoxia. Following growth under anoxia, CF isolates 5 and 7 retained their protease activity, whilst this 
was below the limit of detection for PAO1. CF isolate 6 failed to produce detectable proteases following growth 
under normoxia and anoxia.
P. aeruginosa PAO1 has previously been shown to lyse S. aureus16. Thus, the ability of P. aeruginosa CF isolates 
to lyse heat-killed S. aureus was also determined following growth under normoxia and anoxia, a method used 
previously53–55. As shown in Fig. 3b, CF isolate 6 was the only isolate unable to significantly lyse heat-killed S. 
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Figure 2. S. aureus and P. aeruginosa sessile viability in mono- and co-culture biofilms under normoxia and 
anoxia. Bacteria were grown in 96-well flat bottom plates either individually or in a 1:1 ratio for 24 h at 37 °C 
under static normoxia or anoxia. Biofilms were washed, detached, vortexed, serially diluted and plated onto 
selective agar for quantification. Bars represent the mean ± S.E.M of three individual experiments (N = 3), each 
performed in triplicate. Statistical differences were determined using one-way ANOVA with Tukey’s post-hoc. 
*P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 3. Impact of normoxia and anoxia upon the production of anti-staphylococcal exoproducts by 
P. aeruginosa. (a) Protease production was determined following the addition of P. aeruginosa cell-free 
supernatants to wells in milk agar, prior to the diameter of the zones of clearance (mm) being measured 
following 24 h incubation. (b) P. aeruginosa cell-free supernatants were added to heat-killed S. aureus and 
staphylolytic activity was determined by measuring changes in the OD595 after 60 min. The control consisted 
of heat-killed S. aureus with sterile LBN broth only. (c) Pyocyanin was extracted from P. aeruginosa cell-free 
supernatants using chloroform and 0.2 M hydrochloric acid. Spectrophotometric measurements were taken at 
OD520 and multiplied by extinction co-efficient of pyocyanin at this wavelength (17.072) to express pyocyanin 
in µg/mL. (d) Pyoverdine production was quantified by measuring the relative fluorescence units (RFU) of P. 
aeruginosa cell-free supernatants following excitation at 460 nm and emission at 490 nm. (e) Surfactant activity 
was measured using the established drop collapse assay, where cell-free supernatants were serially diluted (1:1) 
with deionised water containing 0.005% crystal violet to aid visualisation. Surfactant scores are equal to the 
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aureus under normoxia (P > 0.05). Following growth under anoxia (Fig. 3b), PAO1 lost its ability to significantly 
lyse heat-killed S. aureus compared to normoxia (P < 0.001), whilst CF isolates 5 and 7 retained their significant 
staphylolytic activity under anoxia. CF isolate 6 did not lyse heat-killed S. aureus under anoxia.
The complete cell-free secretomes of P. aeruginosa PAO1 and CF isolates 5, 6 and 7 are shown in Supplementary 
Tables S2 to S5. Expression levels of elastase and protease LasA following growth under normoxia and anoxia 
were studied by mass spectrometry (Fig. 4) to determine whether there was any correlation with the protease and 
staphylolytic activity shown in Fig. 3a,b. As shown in Fig. 4, whilst all of the isolates tested secreted detectable 
levels of elastase under both environmental conditions, CF isolate 6 was the only isolate which did not produce 
detectable levels of protease LasA under both normoxia and anoxia. Analysis of the PAO1 cell-free secretome 
demonstrated a 20.2-fold decrease in the relative abundance of elastase under anoxia, whilst exhibiting a minimal 
fold change in protease LasA. Conversely, CF isolates 5 and 7 exhibited a 3.0-fold increase and 1.4-fold decrease in 
elastase respectively, along with a 3.0-fold increase and 1.3-fold decrease in protease LasA. Once more, CF isolate 
6 failed to exhibit staphylolytic activity under anaerobiosis (Fig. 4b), with no protease LasA being detected in its 
secretome (Fig. 4).
The production of the respiratory inhibitor pyocyanin was also determined. Under normoxia, PAO1 and CF 
isolates 5 and 6 produced varying degrees of pyocyanin following phenol-chloroform extraction, whilst this was 
below the limit of detection for CF isolate 7 (Fig. 3c). No pyocyanin was detected for any of the P. aeruginosa 
isolates following growth under anoxia.
As shown in Fig. 3d, P. aeruginosa PAO1 and CF isolate 5 produced pyoverdine under normoxia, with this 
being significantly reduced under anoxia (P < 0.001). CF isolates 6 and 7 produced minimal levels of pyoverdine, 
which was unaffected by anoxia. Lastly, PAO1 and all CF isolates tested exhibited varying degrees of biosurfactant 
activity, with this being the greatest for CF isolate 7 (Fig. 3e). Anoxia reduced the surfactant activity of PAO1 and 
CF isolate 5, but not for CF isolates 6 and 7. The data shown in Fig. 3 demonstrates that each P. aeruginosa CF 
isolate produces a varying array of anti-staphylococcal exoproducts under normoxia, with their production being 
further influenced by anoxia.
Using these data, we sought to greater determine the nature of the P. aeruginosa anti-staphylococcal com-
pound which mediates P. aeruginosa dominance under both normoxia and anoxia. Cell-free supernatants from 
P. aeruginosa cultures were passed through 3 kDa molecular weight cut-off filters, in an effort to determine the 
size of the anti-staphylococcal compound. Whilst the 20 kDa protease LasA would be retained within the >3 kDa 
fraction, smaller virulence factors such as pyocyanin, rhamnolipids and pyoverdine would pass into the <3 kDa 
fraction. Heat-treatment was used to determine whether the anti-staphylococcal compound was proteinaceous 
in nature, as boiling would be expected to abolish its anti-staphylococcal activity. Cell-free culture supernatants 
were subsequently added to log-phase cultures of S. aureus to assess their ability to inhibit S. aureus planktonic 
growth over 14 h.
As shown in Fig. 5, under normoxia, P. aeruginosa PAO1 whole supernatant, >3 kDa and <3 kDa frac-
tions were able to significantly reduce S. aureus growth compared to S. aureus alone (P < 0.001). This 
anti-staphylococcal activity was not lost following heat-treatment of the fractions. Interestingly, S. aureus antag-
onism across all the CF clinical isolates tested under normoxia were restricted to the whole supernatant and 
>3 kDa fractions only, which was unaffected by heat-treatment.
Under anoxia (Fig. 5) significant anti-staphylococcal activity was detected in all but the untreated <3 kDa 
fraction of PAO1. Once again, the anti-staphylococcal activity of the fractions was unaffected by heat-treatment. 
The heat-treated whole culture supernatant and both the untreated and heat-treated >3 kDa fractions obtained 
from CF isolate 5 significantly reduced S. aureus growth. For CF isolate 6, only the >3 kDa fractions significantly 
reduced S. aureus growth, where once again, heat-treatment failed to abolish this activity. As seen with CF iso-
late 5, the heat-treated whole culture supernatant and the untreated and heat-treated >3 kDa fractions obtained 
from CF isolate 7 were the most inhibitory towards S. aureus growth. Collectively, this suggests that the major 
anti-staphylococcal exoproduct produced by P. aeruginosa is heat-stable and >3 kDa in size.
Proteomic analysis of the cell-free secretomes of PAO1 and CF isolates 5, 6 and 7 (Supplementary Tables S2 to 
S5) did not identify any obvious lead candidate for the active factor which is likely to mediate P. aeruginosa dom-
inance under normoxia and anoxia. Whilst the mass spectrometry experiments performed were used to generate 
a proteomic dataset only, it is possible that the extracellular anti-staphylococcal factor is not proteinaceous in 
nature. Thus, further work is required in order to identify the active anti-staphylococcal factor.
Impact of S. aureus exoproducts and anoxia upon P. aeruginosa motility. Lastly, as S. aureus infec-
tion precedes P. aeruginosa, we sought to determine the influence of S. aureus exoproducts upon P. aeruginosa 
swimming and swarming motilities. Both free and surface attached forms of motility are likely to play important 
roles in airway colonisation and disease progression. The impact of anoxia upon P. aeruginosa motility in the 
presence and absence of S. aureus exoproducts was also determined.
PAO1 and the CF isolates tested exhibited varying degrees of swimming motility under normoxia (Fig. 6). CF 
isolate 5 alone exhibited significantly greater swimming motility under normoxia compared to PAO1, CF isolate 6 
and CF isolate 7 alone (P < 0.001). P. aeruginosa motility was unaffected by the inclusion of S. aureus exoproducts. 
Under anoxia, CF isolate 5 alone exhibited the greatest swimming motility compared to PAO1 alone (P < 0.01) 
and CF isolates 6 and 7 alone (P < 0.05). Compared to normoxia, anoxia reduced the swimming motility of PAO1 
reciprocal of the greatest dilution at which there was surfactant activity. Data shown are the mean ± S.E.M. of 
three independent experiments (N = 3), each performed in triplicate. In panels A, B and D, statistical differences 
were determined using one-way ANOVA with Tukey’s post-hoc test *P < 0.05, **P < 0.01 and ***P < 0.001.
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alone (P < 0.01), CF isolate 5 alone (P < 0.001) and CF isolate 5 in the presence of S. aureus (P < 0.001). PAO1 
alone lost its swimming motility under anoxia whilst the addition of S. aureus cell-free supernatant significantly 
restored the swimming motility of PAO1 (P < 0.001). S. aureus cell-free supernatant also enhanced the swimming 
motility of CF isolate 7 compared to CF isolate 7 alone (P < 0.01).
Under normoxia, CF isolate 5 alone exhibited the greatest swarming motility compared to PAO1 and CF 
isolates 6 and 7 alone (P < 0.001) (Fig. 6). The addition of S. aureus exoproducts only enhanced the swarming 
motility of PAO1 (P < 0.001). Under anoxia, CF isolate 5 exhibited the greatest swarming motility compared to 
PAO1, including CF isolates 6 and 7 alone (P < 0.001). S. aureus exoproducts did not modulate P. aeruginosa 
swarming motility under anoxia. Only CF isolate 5 alone exhibited a significant reduction in swarming motility 
under anoxia compared to normoxia (P < 0.01).
As S. aureus exoproducts were shown to modulate the swimming motility of PAO1 and CF isolate 7 under 
anoxia, including the swarming motility of PAO1 under normoxia (Fig. 6), S. aureus cell-free supernatants were 
subjected to size fractionation and heat-treatment to determine the size and nature of the effector compound(s). 
As shown in Fig. 7, all fractions regardless of size and heat-treatment were able to modulate P. aeruginosa motility 
to the same extent as the whole culture supernatants (Fig. 6).
Discussion
It is now appreciated that mucus plugging, decreases in pulmonary function and the consumption of oxygen by 
polymicrobial communities and host neutrophils create microenvironments in CF airways which are devoid of 
oxygen31,56. Whilst previous studies have demonstrated anaerobiosis attenuates the growth and virulence of P. 
aeruginosa laboratory strains and clinical isolates43,44, this study aimed to provide novel insights into the impact 
of anaerobiosis upon the interactions of S. aureus and CF clinical isolates of P. aeruginosa in planktonic co-culture 
and mixed species biofilms, including the possible mechanisms governing interspecies interactions under both 
environmental conditions.
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Figure 4. Detection of elastase and protease LasA in the P. aeruginosa cell-free secretome. Cell-free 
supernatants obtained from 24 h cultures of PAO1 and CF isolates 5, 6 and 7 grown under normoxia (+) and 
anoxia (−) were subject to protein precipitation, SDS-PAGE electrophoresis and MS analysis. Data represents 
N = 1 from five pooled samples. The abundance of elastase and protease LasA is expressed as fold-change 
compared to normoxia.
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Figure 5. Heat-treatment and size fractionation of P. aeruginosa cell-free supernatants upon the growth of S. 
aureus. Cell-free supernatants from P. aeruginosa grown under normoxia or anoxia were added to standardised 
S. aureus directly or were first subjected to 3 kDa size fractionation, with select fractions then being subjected 
to boiling. Plates were incubated at 37 °C for 14 h and the OD470 of S. aureus cultures read at hourly intervals. 
Plots represent the mean OD at 14 h ± S.D. of two individual experiments (N = 2), each performed in duplicate. 
WS: Whole supernatant, WSHI: Whole supernatant heat-inactivated, >3: greater than 3 kDa, >3HI: greater 
than 3 kDa heat-inactivated, <3: less than 3 kDa, <3HI: less than 3 kDa heat-inactivated. Statistical differences 
were determined using one-way ANOVA with Dunnett’s post-hoc (versus S. aureus only control). *P < 0.05, 
**P < 0.01 ***P < 0.001.
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Our competition data showed oxygen availability exerts a major role in S. aureus and P. aeruginosa competi-
tion in both planktonic co-culture and mixed species biofilms. Under normoxia (Fig. 1), PAO1 and all CF isolates 
5, 6 and 7 were all able to outcompete S. aureus in planktonic co-culture at 24 h, without their own growth being 
adversely affected. This finding is supported by other in vitro studies conducted under normoxia where P. aerugi-
nosa CF isolates were shown to reduce the viability of S. aureus in planktonic culture25,27,57. In all planktonic 24 h 
co-culture experiments, P. aeruginosa was unable to completely kill S. aureus.
PAO1 and CF isolates 5 and 7 retained their ability to antagonise S. aureus growth in mixed species biofilms 
under normoxia, whilst CF isolate 6 did not (Fig. 2). The inability of CF isolate 6 to outcompete S. aureus in mixed 
species biofilms as in planktonic co-culture (Figs 1 and 2) is potentially explained by previous studies which 
demonstrate differences in bacterial virulence following growth in planktonic and biofilm culture58–60.
The introduction of anoxia caused PAO1 and CF isolates 5 and 6 to lose their ability to outcompete S. aureus 
in both planktonic co-culture and mixed species biofilms (Figs 1 and 2), where S. aureus was enumerated in 
densities seen in monoculture. These results support those of a previous study which demonstrated anaerobi-
osis reduced the ability of P. aeruginosa PAO1 to induce zones of clearance upon confluent bacterial lawns of 
Staphylococcus epidermidis61. Furthermore, the culture of P. aeruginosa strains under hypoxia (1% oxygen) has 
previously been shown to attenuate P. aeruginosa virulence in an in vivo model of infection compared to nor-
moxia through decreased expression of several virulence factors62. From these data, it is possible that anoxia is 
one of several mechanisms facilitating isolate specific S. aureus-P. aeruginosa co-existence in the CF lung.
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Figure 6. Effect of S. aureus culture supernatant and oxygen upon P. aeruginosa motility. Swimming and 
swarming motilities of P. aeruginosa isolates were assessed following an overnight incubation on swimming 
and swarming agar plates. To test the effects of S. aureus culture supernatant upon these two forms of motility, 
a 1:100 dilution of the culture supernatant was added to plates before the agar set. Data are presented as 
mean ± S.E.M from three independent experiments each performed in duplicate. Statistical differences were 
determined using one-way ANOVA with Tukey’s post-hoc. **P < 0.01 ***P < 0.001.
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Figure 7. Heat-treatment and size fractionation of S. aureus cell-free supernatants upon P. aeruginosa 
swimming and swarming motility. Swimming and swarming motilities of the select P. aeruginosa isolates were 
assessed following an overnight incubation on swimming and swarming agar plates. S. aureus only motility 
values were taken from Fig. 6. WS: whole supernatant fractions of S. aureus culture supernatant were taken 
from Fig. 6. Plates were supplemented with a 1:100 dilution of S. aureus culture supernatant fractions (>3 
or <3 kDa), with select fractions also being subject to heat-treatment. >3: greater than 3 kDa, >3HI: greater 
than 3 kDa heat-inactivated, <3:less than 3 kDa, <3HI: less than 3 kDa heat-inactivated. Data are presented as 
mean ± S.D from two independent experiments (N = 2) each performed in duplicate. Statistical differences were 
determined using one-way ANOVA with Dunnett’s post-hoc (versus WS: whole supernatant only).
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Interestingly, CF isolate 7 was the only P. aeruginosa isolate able to reduce S. aureus viability under anoxia, in 
both planktonic co-culture and mixed species biofilm (Figs 1 and 2). To greater understand this phenomenon, 
the production of several anti-staphylococcal exoproducts was assessed across isolates, following growth under 
normoxia and anoxia. The use of molecular weight cut off filters and heat-treatment of the cell-free fractions 
served to determine the size and nature of the anti-staphylococcal compound likely to be mediate P. aeruginosa 
dominance under normoxia and anoxia.
PAO1 has previously been shown to produce LasA, responsible for cleaving the peptidoglycan cell wall of S. 
aureus24,63. Unlike CF isolate 6, PAO1 and CF isolates 5 and 7 were able to lyse heat-killed S. aureus under nor-
moxia (Fig. 3b). PAO1 lost its staphylolytic ability under anoxia however (Fig. 3b), a finding supported by reports 
of a decrease in the transcription of LasA for PAO1 under anoxia64 and a reduction in PAO1 elastase B (LasB) pro-
duction under anoxia44. Perhaps the LasA produced by PAO1 following growth under anoxia is below a threshold 
to exert a considerable affect upon S. aureus viability compared to that produced by CF isolates 5 and 7, although 
further work is required to determine this. S. aureus has also previously been shown to exhibit an increase in cell 
wall thickness under anaerobiosis65 and whilst this was not investigated in this study, this mechanism may further 
reduce S. aureus susceptibility to P. aeruginosa LasA under anoxia.
Whilst LasA may be advantageous to P. aeruginosa under growth in polymicrobial communities with S. 
aureus, collectively, LasA mediated lysis of S. aureus alone does not appear to be essential for facilitating P. aerug-
inosa dominance under normoxia. All CF isolates were able to outcompete S. aureus in planktonic co-culture 
(Fig. 1), yet CF clinical isolate 6 failed to exhibit detectable staphylolytic activity (Fig. 3b) or secrete detectable 
protease LasA as determined by mass spectrometry (Fig. 4). LasA also does not appear to be essential for mod-
ulating P. aeruginosa dominance under anoxia, as CF isolates 5 and 7 both retained their staphylolytic activity 
under anoxia (Fig. 3b). Only CF isolate 7 was able to outcompete in planktonic co-culture (Fig. 1) and mixed 
species biofilm (Fig. 2). Furthermore, whilst whole culture supernatants and >3 kDa fractions from PAO1 and 
the CF isolates were able to antagonise S. aureus growth, heat-treatment failed to abolish their inhibitory activity 
(Fig. 5). As staphylolysis is known to be mediated by LasA, boiling such fractions would be expected to denature 
this 20 kDa protease.
The role of LasA in governing interspecies interactions may also be complicated by previous findings which 
demonstrate how the growth of S. aureus in the presence of P. aeruginosa LasA and staphylolysin produced by 
Staphylococcus staphylolyticus, selects for S. aureus colonies which lack a cell wall66,67. Whilst the emergence of 
such colonies in CF airways requires further study, selection of such a phenotype may serve to facilitate S. aureus 
persistence under both normoxia and anoxia in the presence of P. aeruginosa.
As previously mentioned, pyocyanin inhibits S. aureus oxidative respiration, causing a reduction in 
growth. PAO1 and CF isolates 5 and 6 produced detectable levels of pyocyanin under normoxia following 
phenol-chloroform extraction, whilst this was below the limit of detection for CF isolate 7 (Fig. 3c). Despite this, 
CF isolate 7 was still able to dominate S. aureus under normoxia in planktonic co-culture (Fig. 1) and mixed 
species biofilms (Fig. 2). Furthermore, pyocyanin was below the limit of detection for all culture supernatants 
cultured under anoxia following phenol-chloroform extraction (Fig. 3c), yet CF isolate 7 was still able to domi-
nate. Whilst the inability to detect pyocyanin under anoxia may be due to the redox nature of the phenazine68, a 
previous study demonstrated that hypoxia significantly reduced pyocyanin production by P. aeruginosa69.
Proteins involved in phenazine biosynthesis were only detected in the secretomes of P. aeruginosa PAO1 and P. 
aeruginosa CF isolate 5. As shown in Supplementary Table S2, P. aeruginosa PAO1 exhibited a 10.4-fold decrease 
in phenazine biosynthesis protein PhzB 1 and a 12.3-fold decrease in phenazine biosynthesis protein PhzB 2 
respectively under anoxia. Additionally, there was a 21.0-fold decrease in Phenazine biosynthesis protein PhzB 
1 for P. aeruginosa CF isolate 5 under anoxia (Supplementary Table S3). These data support the phenotypic data 
relating to pyocyanin production shown in Fig. 3c.
Size exclusion and heat-treatment of the P. aeruginosa cell-free supernatants also demonstrated that S. aureus 
antagonism was restricted to the >3 kDa fraction and was not abolished following heat-treatment (Fig. 5). 
However, it is expected that pyocyanin would be present in the <3 kDa fraction and that heat-treatment would 
abolish its activity.
Pyoverdine production by P. aeruginosa is known to reduce S. aureus growth, and enhance P. aeruginosa vir-
ulence27,29,70. As shown in Fig. 3d, PAO1 and CF isolate 5 produced large amounts of pyoverdine. Furthermore, 
anoxia was shown to significantly reduce pyoverdine production by PAO1 and CF isolate 5 compared to nor-
moxia, a finding also reported following the growth of P. aeruginosa under hypoxia69. Despite CF isolates 6 and 
7 producing minimal amounts of pyoverdine under normoxia (Fig. 3d), all P. aeruginosa CF isolates were able to 
outcompete S. aureus in planktonic co-culture (Fig. 1). Additionally, CF isolate 7 was able to outcompete S. aureus 
under anoxia despite producing minimal amounts of pyoverdine. As the antimicrobial activity of P. aeruginosa 
cell-free supernatants was restricted to the >3 kDa fractions (Fig. 5), it is unlikely that siderophore production in 
isolation drives S. aureus antagonism. However, we recognise the importance of pyoverdine in governing inter-
species interactions may be underestimated in this study as iron-depleted growth media was not used to culture 
P. aeruginosa.
The surfactant activity of P. aeruginosa rhamnolipids has been previously shown to target S. aureus and reduce 
its viability71–73. Our data demonstrated that PAO1 and the CF P. aeruginosa isolates tested harboured biosur-
factant activity under normoxia, with this being the greatest for CF isolate 7 (Fig. 3e). Whilst CF isolate 7 retained 
its high surfactant score under anoxia, size exclusion studies demonstrated that the anti-staphylococcal activ-
ity for all isolates was restricted to the >3 kDa fraction under both normoxia and anoxia (Fig. 5) and yet it is 
expected that the rhamnolipids would be retained within the <3 kDa fractions.
Collectively, it is reasonable to suggest from the results of this study that the anti-staphylococcal compound 
which facilitates P. aeruginosa dominance under both normoxia and anoxia is heat-stable, >3 kDa in size 
and is likely not one of the anti-staphylococcal factors studied. An interesting observation in Fig. 5 is that the 
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heat-treated whole supernatant and >3 kDa fractions for most P. aeruginosa CF isolates under normoxia and 
anoxia appeared to more greatly reduce S. aureus growth compared to those which had not been heat treated. It 
is reasonable that heating may either increase the activity of the anti-staphylococcal factor, or alternatively lead 
to the loss of a factor within the supernatant which may otherwise protect S. aureus directly or indirectly. We 
also recognise that a limitation of this study is that the absolute concentration of the P. aeruginosa exoproducts in 
cell-free culture supernatants was not determined and it may be that some of the virulence factors were at con-
centrations too low to exert an antagonistic effect upon S. aureus.
P. aeruginosa is known to employ several other virulence properties which were not characterised in this 
study and may contribute to the differences seen in bacterial competition. This includes the respiratory inhibitor 
hydrogen cyanide74. However, its role in governing S. aureus-P. aeruginosa interactions is likely to be minimal 
in this study as it would be found in the <3 kDa fraction, and yet these fractions did not exert considerable 
anti-staphylococcal activity upon exposure to planktonic S. aureus under normoxia (Fig. 5). Furthermore, pre-
vious research has demonstrated that hydrogen cyanide is rapidly inactivated under strict anoxia75 and thus its 
ability to reduce S. aureus viability under anoxia is considered minimal.
P. aeruginosa also produces the respiratory inhibitor HQNO, which is known to reduce S. aureus viabil-
ity19,27,76. Its production is regulated by Pseudomonas quinolone signal (PQS)77. PQS production is known to 
be suppressed under anoxia61,78. As shown in Supplementary Table S5, PQS proteins were only detected in the 
secretome of P. aeruginosa CF isolate 7. Whilst there was a 9.4-fold decrease in PqsB under anoxia, there was a 
4.5-fold increase in PqsC under anoxia. Thus, further work is required to determine the role of HQNO in govern-
ing S. aureus-P. aeruginosa interspecies interactions.
It is also reasonable to suggest that the ability of P. aeruginosa to dominate under both normoxia and anoxia 
is not due to the secretion of a single anti-staphylococcal factor, but is due to the production of many20,27,79–81. A 
previous study has reported that deletion of a single virulence property has been shown to reduce P. aeruginosa 
antagonism towards S. aureus82. The production of alginate by P. aeruginosa has been reported to facilitate S. 
aureus-P. aeruginosa co-existence within the CF lung, with the overproduction of alginate inhibiting the synthesis 
secretion of pyoverdine, HQNO and rhamnolipids82. However, as none of the P. aeruginosa CF isolates used in 
this study were mucoid, alginate is unlikely to play a role in facilitating interspecies co-existence.
Finally, we also show how not all S. aureus-P. aeruginosa interactions studied are antagonistic. Whilst S. 
aureus has previously been shown to enhance P. aeruginosa antibiotic resistance83,84, we have demonstrated that S. 
aureus exoproducts were able to restore and enhance P. aeruginosa swimming and swarming motility in an isolate 
dependent manner under normoxia and anoxia (Fig. 6).
Previous research has demonstrated that the intracellular accumulation of the signalling molecule bis-
(3′-5′)-cyclic dimeric GMP (c-di-GMP) favours P. aeruginosa biofilm formation85 through the production of 
exopolysaccharide, whilst repressing flagella motility. Conversely, intracellular decreases in c-di-GMP inhib-
its exopolysaccharide production and promotes flagella mediated motility86,87. These effects of intracellular 
c-di-GMP are mediated through its ability to bind and modulate the transcriptional regulator FleQ88,89. It is 
possible that one or more S. aureus exoproducts within the cell-free supernatant may lower the intracellular con-
centration c-di-GMP in P. aeruginosa, promoting motility (Fig. 6). Additional work is required as the modulating 
ability of S. aureus culture supernatant upon P. aeruginosa motility was not seen in all isolates and could not be 
restricted to a single fraction (Fig. 7).
Twitching motility in the presence and absence of S. aureus exoproducts was also investigated but in our hands 
no twitching motility was detected in any strains. As anoxia was also shown to influence P. aeruginosa motility, 
the presence of S. aureus and changes in oxygen availability are both likely to influence P. aeruginosa colonisation 
and dissemination into microenvironments within the CF lung.
Conclusion
This study provides novel findings concerning the impact of anoxia upon interactions between S. aureus and CF 
isolates of P. aeruginosa in mixed planktonic culture and mixed species biofilms. We hypothesise from our data 
that anoxia is one of several potential mechanisms facilitating S. aureus-P. aeruginosa co-existence in the CF lung, 
with co-infection having been associated with poor clinical outcomes and a worsening of pulmonary function in 
CF20,90. However, not all P. aeruginosa CF isolates lose their ability to antagonise S. aureus growth under anoxia. 
Further work is required to determine the nature of the major anti-staphylococcal compound which facilitates P. 
aeruginosa dominance under both normoxia and anoxia, although this study provides evidence that the factor is 
likely to be heat-stable and >3 kDa in size. The ability of select P. aeruginosa CF isolates to retain their virulence 
and motility under anoxia is likely to influence disease progression differently across the CF population. The abil-
ity of S. aureus exoproducts to further modulate P. aeruginosa motility in an isolate dependent manner, reinforces 
the complex interspecies interactions known occur within the CF lung.
As co-isolated strains of S. aureus and P. aeruginosa are shown to be less antagonistic than those from 
mono-infected patients82, a longitudinal study of select S. aureus and P. aeruginosa co-isolates could be per-
formed. This would allow interspecies interactions and the pathoadaptive mechanisms that occur overtime in 
both S. aureus and P. aeruginosa to be studied in greater detail and allow comparisons to be made under different 
environmental conditions. It is hoped that this study encourages interspecies interactions of other key CF patho-
gens to be determined under anoxia, an environmental condition shown to be important in modulating bacterial 
virulence and interspecies interactions.
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Materials and Methods
Bacterial strains and growth conditions. All bacterial strains used in this study are listed in Table 1, 
with Table 2 describing their colony morphotype following growth upon LB agar. Eight clinical isolates of P. 
aeruginosa were cultured from paediatric CF sputum samples from Birmingham Children’s Hospital, UK between 
1990–1999. All bacterial strains were stored at −80 °C in 50% (v/v) glycerol/water. Bacteria were streaked from 
frozen stocks to Luria Bertani (LB) agar plates (Fisher Scientific, UK) and incubated at 37 °C for 48 h. Strains were 
identified using selective agar, Gram staining and biochemical testing.
All assays were carried out using standardised bacterial inoculum. Single well isolated colonies of S. aureus or 
P. aeruginosa were routinely inoculated into 10 mL of sterile LBN broth (LB broth supplemented with 1% (w/v) 
potassium nitrate) (Fisher Scientific, UK) and grown at 37 °C under static conditions of normoxia or anoxia (min-
iMACS anaerobic workstation, Don Whitley Scientific, UK) for approximately 16 h.
Cross-Streak assay on solid agar. Overnight cultures of S. aureus and P. aeruginosa grown separately 
under normoxia or anoxia were pelleted, resuspended in fresh broth and adjusted to an OD470 of 1.0. A sterile 
cotton swab was immersed in a given P. aeruginosa standardised culture and streaked horizontally across the 
surface of a LB agar plate. After air drying for 20 min, a sterile cotton swab was immersed in the adjusted S. aureus 
culture and cross-streaked vertically across the surface of the agar plate. Plates were then incubated either under 
normoxia or anoxia at 37 °C for 18 h, prior to being visually inspected for growth inhibition.
Mono-culture and co-culture planktonic growth curves. All growth curve experiments were con-
ducted in 250 mL conical flasks containing 50 mL of LBN broth at 37 °C under static conditions. Overnight cul-
tures of S. aureus and P. aeruginosa CF isolates grown under normoxia or anoxia were pelleted, resuspended in 
fresh medium and adjusted to an OD470 of 1.0. For co-culture growth curves, the bacteria were inoculated at an 
equal ratio (1:1, S. aureus to P. aeruginosa) and incubated under static conditions at 37 °C for 24 h. Samples were 
taken at regular intervals, serially diluted in sterile PBS (Fisher, UK) and 20 µL spots plated onto Pseudomonas 
isolation agar (PIA) (Fisher Scientific, UK) and mannitol salt agar (MSA) (Fisher Scientific, UK) to allow species 
differentiation. The plates were incubated for approximately18 h, prior to enumerating the colony forming units 
(CFU/mL).
The competition index (CI) and Relative Increase Ratio (RIR) were calculated. The RIR was calculated on 
single growth curve data using the P. aeruginosa-S. aureus ratio at a given time point, divided by the same ratio at 
time point 0 h (inoculum). The same ratio was used to calculate the CI, although this used data from the mixed 
culture. A CI that differs statistically from the RIR indicates competition between the two organisms. This method 
was adapted from Macho et al.91.
Mono-culture and co-culture biofilm formation. Overnight cultures of S. aureus and P. aeruginosa 
grown under normoxia or anoxia were centrifuged and adjusted to an OD470 of 1.0. Cultures were diluted tenfold 
and 100 µL added to the central wells of a 96-well tissue culture treated flat bottom plate, either individually or 
in a 1:1 ratio for an hour under static conditions, at 37 °C. An equal volume of broth was added to the individual 
culture to compensate for any dilution effect. After 60 min, the well contents were aspirated and replaced with 
fresh LBN broth. Plates were incubated for a further 24 h at 37 °C under static conditions. Following this, biofilms 
were washed twice using 200 µL of PBS, detached using 100 µL of 0.25% trypsin-EDTA (Fisher Scientific, UK), 
collected, vortexed for 70 s, serially diluted and plated onto PIA (Fisher, UK) and MSA (Fisher Scientific, UK). 
The plates were incubated for approximately18 h, prior to enumerating the colony forming units (CFU/mL).
preparation of P. aeruginosa cell-free culture supernatant. Overnight cultures of P. aeruginosa 
grown under normoxia or anoxia were centrifuged at 4,000 x g for 10 min at 4 °C. Each supernatant was sterile 
filtered with a low-binding 0.22 µm polyethersulfone membrane filter (Corning, USA) and stored at −20 °C until 
needed. To confirm sterility after each preparation, a small volume of supernatant was streaked onto LB agar 
plates and incubated for approximately 20 h prior to reading. For size exclusion experiments, 10 mL of cell-free 
supernatant was added to a 3 kDa molecular weight cut off protein concentrator (ThermoFisher, UK) and centri-
fuged at 4,000 × g for 1 h. Apical and basal volumes were subsequently added to 2.0 mL sterile microcentrifuge 
Strain Species Source Reference
6538 S. aureus American Type Culture Collection (ATCC)
99
PAO1 P. aeruginosa Wound exudate, Melbourne, Australia 100
Isolate 1
P. aeruginosa CF Sputum from Birmingham Children’s Hospital, Birmingham, UK This study
Isolate 2
Isolate 3
Isolate 4
Isolate 5
Isolate 6
Isolate 7
Isolate 8
Table 1. S. aureus and P. aeruginosa strains used in this study.
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tubes (Fisher Scientific, UK). For heat-treatment, microcentrifuge tubes containing cell-free supernatant were 
added to a heat block and boiled at 95 °C for 10 mins, prior to cooling.
Determination of total protease production. Protease production was determined using skimmed 
milk agar. Cell-free supernatants (40 µL) from overnight cultures were loaded into wells in agar plates and incu-
bated at 37 °C for 24 h. Hydrolysis of the milk protein casein results in a clear zone surrounding the bacterial 
supernatant and would show evidence of protease production. LBN medium was also loaded as a negative con-
trol. Clearance zone diameters were measured with a ruler in millimetres (mm).
Staphylolytic activity. This method was adapted from92,93. An overnight culture of S. aureus grown under 
static normoxia was centrifuged at 4,000 × g for 10 min at 4 °C, prior to the pellet being resuspended in 250 µL of 
25 mM diethanolamine buffer (Sigma, UK), pH 9.5. The bacteria were then heated to 100 °C for 10 min, before 
being diluted to a final optimal density OD595 of 1.0. 400 µL of the adjusted heat-killed S. aureus was then added 
to each microtube (Fisher, UK). The cell-free supernatant from each P. aeruginosa isolate was diluted 1:10 with 
diethanolamine buffer, prior to 100 µL being added to the heat-killed S. aureus. Bacterial lysis was determined by 
measuring decreases in heat killed S. aureus OD595 after 60 min on a MultiSkan Go plate reader (ThermoFisher, 
UK). LBN broth alone was used as a control.
Pyocyanin extraction and quantification. This method was adapted from94,95. Overnight cultures of 
P. aeruginosa grown under normoxia or anoxia were pelleted, resuspended in fresh medium and adjusted to an 
OD470 of 1.0. For single cultures, 500 µL of P. aeruginosa was then added to a 250 mL conical flask containing 
50 mL of LBN broth (1:100 dilution). The flasks were then incubated at 37 °C for 24 h, under static normoxia or 
anoxia. To quantify pyocyanin production, bacterial cells were pelleted by 4,000 × g centrifugation for 25 min at 
4 °C and the supernatant sterile filtered with a low-binding 0.22 µm polyethersulfone membrane filter (Corning, 
USA). 7.5 mL of the sterile supernatant was added to 4.5 mL of chloroform and vortexed for ten, 2 s intervals. The 
sample was centrifuged at 4,000 × g for 1 min at 4 °C, prior to 3 mL of the blue-green phase (chloroform phase) 
being aspirated into a new tube. 1.5 mL of 0.2 M hydrochloric acid was then added to the tube and vortexed again 
for ten, 2 s intervals, prior to centrifugation at 4,000 × g for 1 min at 4 °C. 100 µL of the pink coloured phase was 
then transferred into a 96-well plate in triplicate. 100 µL of hydrochloric acid was added in triplicate as a control. 
The plate was then read at OD520 and multiplied by the extinction co-efficient 17.072 to determine the concentra-
tion of pyocyanin per mL of supernatant94.
Pyoverdine fluorescence spectroscopy. A total of 100 µL of each P. aeruginosa cell-free supernatant was 
added to a black 96-well plate (Griener Bio One, UK) in triplicate and read at excitation and emission wavelengths 
of 400/460 nm as performed previously96,97 on a Gemini XS Spectramax (Molecular Devices, USA) fluorescence 
plate reader. The background level of fluorescence was measured using 100 µL LBN broth only.
Drop collapse assay. Cell-free supernatants from overnight cultures of P. aeruginosa were serially diluted (1:1) in 
sterile dH2O containing 0.005% crystal violet to aid visualisation. A total of 20 µL of each dilution (including neat super-
natant) were spotted onto the underside of a lid of a 96-well plate and the plate titled at 90°, as performed previously82. 
The assay works on the principle that if the droplet contains surfactants, the drops spread. However, as the quantity of 
surfactants decrease by dilution, the droplet eventually beads up due to an increase in surface tension. Surfactant scores 
are equal to the reciprocal of the greatest dilution at which there was surfactant activity (a collapsed drop).
Isolate
Pigmentation Colony Size Mucoidy status Form
Optical 
Property
Autolysis
Surface Texture
Brown Green White Opaque Small Large Mucoid
Non-
mucoid Circular Irregular Opaque Rough Smooth
PAO1 + + + + + − +
1 + + + + + + − +
2 + + + + + − +
3 + + + + + − +
4 + + + + + + − +
5 + + + + + − +
6 + + + + + − +
7 + + + + + − +
8 + + + + + − +
Table 2. Colony morphology of P. aeruginosa laboratory strain PAO1 and clinical CF isolates upon LB agar 
plates. The production of four colony pigmentations were studied. Colonies were positive for mucoidy status 
if they exhibited a slimy appearance. Colony form assessed the basic shape of the colonies. Autolysis assessed 
whether the bacteria grew as colonies that were lysed in their centres, whilst margin determined the edge of the 
colonies.
1 5Scientific RepoRts |          (2019) 9:6748  | https://doi.org/10.1038/s41598-019-42952-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
Secretome analysis. Pooled overnight cultures of P. aeruginosa grown under either normoxia or anoxia 
were pelleted following centrifugation at 4,000 × g for 30 min at 4 °C. The supernatant containing extracellular 
proteins was sterile filtered through a 0.22 µm polyethersulfone membrane filter (Corning, USA). Supernatants 
were concentrated using Amicon 3 kDa cut-off filters (Millipore, UK) prior to precipitation with 25% trichlo-
roacetic acid (TCA; w/v) for 15 min on ice. Proteins were pelleted at 14000 × g for 10 min, and pellets washed 
with acetone. Protein pellets were solubilised in 50 mM pH 7.4 Tris-HCl containing 2 mM CHAPS, 7 M urea and 
7 M thiourea using an ultrasonicating probe (30 s sonication per cycle, 65% full power, 2 cycles), and quantified 
against a BSA calibration curve using the Bradford assay (BioRad, UK). Proteins (30 µg) were reduced in Laemmli 
buffer (Sigma Aldrich, UK) for 15 min at 65 °C, and separated by SDS-PAGE on a 10% gel. Separated proteins 
were stained with Coomassie G250 blue (0.5% w/v in 40% aqueous methanol and 10% glacial acetic acid) for 1 h 
and destained in an aqueous solution of 10% ethanol and 7.5% glacial acetic acid.
Protein in-gel digestion was performed following the method of Schevchenko et al.98, with minor modifi-
cations. Each sample lane was divided into 5 bands, gel bands were excised and diced in a clean polypropylene 
tube using a sterile scalpel. Gel pieces were subsequently destained with 50% acetonitrile in 50 mM ammonium 
bicarbonate, dehydrated with acetonitrile and vacuum dried. Proteins were in-gel digested using trypsin in 3 mM 
ammonium bicarbonate (25:1 protein to trypsin ratio; Trypsin Gold, sequencing, Promega, UK) coupled with 
shaking at 550 rpm at 37 °C overnight. Peptides were extracted for 15 min in an ultrasonic bath initially using a 
volume of acetonitrile equivalent to 50% of sample volume, two times with 150 µL of 50% acetonitrile in 50 mM 
ammonium bicarbonate. Finally 400 µL of pure acetonitrile was used to fully dehydrated the gel pieces and max-
imise peptide extraction. Each time the complete peptide extract was collected in a polypropylene tube. Finally, 
peptide extracts were vacuum dried and stored at −20 °C prior to analysis.
Samples were reconstituted in 50 µL of 3% aqueous acetonitrile and 0.1% formic acid for liquid 
chromatography-coupled tandem mass spectrometry (LC-MS/MS) analysis. Peptides were separated and ana-
lysed using an nLC system (Dionex 3000, ThermoScientific, UK) coupled to 5600 TripleTof (AB Sciex, UK) oper-
ating in information dependent (IDA) mode. Peptide solution (10 µL, ~5 pmol) was injected onto a trap column 
(PepMapTM, C18, 5 µm, 100 Å, 300 µm × 1 mm, ThermoScientific, UK) using 2% of eluent B (98% acetonitrile in 
aqueous 0.1% formic acid) at a flow rate of 30 µL/min. Peptides were subsequently separated on an analytical col-
umn (AcclaimTM, PepMapTM C18, 3 µm, 100 Å, 75 µm × 150 mm, ThermoScientific, UK) with the following gra-
dient: 0–3 min 2% B, 3–48 min 2–45% B, 48–52 min 45–90% B, 52–55 min 90% B, 55–70 min 2% B). Electrospray 
was formed by spraying the nLC eluate at 2500 V using a PicoTipTM emitter (New Objective, Germany). The 
10 most intense ions from each MS survey scan were selected for MS/MS, while acquired ions were temporarily 
excluded from MS/MS acquisition for 30 s. The mass spectrometer was calibrated prior to acquisition to ensure a 
high mass accuracy (<10 ppm) on both MS and tandem mass spectrometry (MS/MS) levels. Relative quantifica-
tion was done using Progenesis QI for proteomics software (version 4, Nonlinear Dynamics, UK). Only protein 
unique peptides were used for relative quantification. MS/MS data were searched using MasconDeamon (ver 
2.5) against the SwissProt database, with the following search restriction parameters: mass tolerance of 0.1 Da for 
MS and 0.6 Da for MS/MS spectra, a maximum of 2 trypsin miscleavages, Pseudomonas aeruginosa taxonomy, 
variable modifications of methionine oxidation and cysteine carbamidomethylation.
Bacterial motility. Swimming motility of P. aeruginosa was investigated using 0.3% (w/v) nutrient agar plates 
supplemented with nutrient broth and 1% (w/v) potassium nitrate. Swarming of P. aeruginosa was determined 
using 0.5% (w/v) nutrient agar plates supplemented with nutrient broth, dextrose and 1% (w/v) potassium nitrate. 
Overnight cultures of P. aeruginosa grown under normoxia or anoxia were adjusted to an OD470 of 1.0 with a total of 
5 µL of culture added to the centre of each plate. To measure the effects of S. aureus on P. aeruginosa motility, a 1:100 
diluted S. aureus cell-free culture supernatant was added to the agar plate. Plates were incubated under normoxia or 
anoxia for 24 h at 37 °C. The diameter of the zone travelled by P. aeruginosa was then measured using a ruler in mm.
Statistical analysis. All results unless otherwise stated are expressed as mean ± S.E.M. Data for each exper-
iment were collected from three independent experiments (N = 3), each performed in triplicate. All statistical 
analyses were performed using GraphPad Prism 6 software (Graphpad, La Jolla, CA, USA) with significance 
being set to P < 0.05. The specific tests used for each experiment are described in the figure legends.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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